(Q24699386)

http://onlinelibrary.wiley.com/doi/10.1111/tan.12047/abstract;jsessionid=722A054417BC6317BBA057312C04E64C.f02t04

19 June 2016

1 August 2017

1 reference

title

Novel factors interfering with human immunodeficiency virus-type 1 replication in vivo and in vitro (English)

2 references

http://onlinelibrary.wiley.com/doi/10.1111/tan.12047/abstract;jsessionid=722A054417BC6317BBA057312C04E64C.f02t04

19 June 2016

http://onlinelibrary.wiley.com/doi/10.1111/tan.12047/abstract;jsessionid=722A054417BC6317BBA057312C04E64C.f02t04

1 August 2017

1 reference

19 June 2016

author name string

E Vicenzi

series ordinal

1

1 reference

1 August 2017

G Poli

series ordinal

2

1 reference

1 August 2017

publication date

1 February 2013

1 reference

http://onlinelibrary.wiley.com/doi/10.1111/tan.12047/abstract;jsessionid=722A054417BC6317BBA057312C04E64C.f02t04

1 August 2017

described at URL

language of work or name

English

19 June 2016

0 references

21 January 2013

81

2

61–71

1 reference

http://onlinelibrary.wiley.com/doi/10.1111/tan.12047/abstract;jsessionid=722A054417BC6317BBA057312C04E64C.f02t04

19 June 2016

Tissue Antigens

1 reference

1 August 2017

volume

81

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

61-71

1 reference

A new classification for HIV-1

1 August 2017

cites work

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

Towards an HIV cure: a global scientific strategy

21 January 2018

1 reference

Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins

21 January 2018

1 reference

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

21 January 2018

1 reference

Long-term symptomless HIV-1 infection in recipients of blood products from a single donor

21 January 2018

1 reference

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

21 January 2018

1 reference

Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells

21 January 2018

1 reference

Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

21 January 2018

1 reference

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

21 January 2018

1 reference

HIV-1 Vif, APOBEC, and intrinsic immunity

21 January 2018

1 reference

Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression

21 January 2018

1 reference

A novel gene of HIV-1, vpu, and its 16-kilodalton product

21 January 2018

1 reference

Modulation of HIV-1-host interaction: role of the Vpu accessory protein

21 January 2018

1 reference

HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms

21 January 2018

1 reference

Interaction of Virion Protein Vpr of Human Immunodeficiency Virus Type 1 with Cellular Transcription Factor Sp1 and trans-Activation of Viral Long Terminal Repeat

21 January 2018

1 reference

Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages

21 January 2018

1 reference

Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex

21 January 2018

1 reference

HIV-1 Vpr: mechanisms of G2 arrest and apoptosis

21 January 2018

1 reference

The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product

21 January 2018

1 reference

SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx

21 January 2018

1 reference

Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein

21 January 2018

1 reference

SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates

21 January 2018

1 reference

Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein

21 January 2018

1 reference

Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm

21 January 2018

1 reference

HIV-1 integration in the human genome favors active genes and local hotspots

21 January 2018

1 reference

The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1.

21 January 2018

1 reference

Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation

21 January 2018

1 reference

Primitive hematopoietic cells resist HIV-1 infection via p21

21 January 2018

1 reference

Drug 9AA reactivates p21/Waf1 and Inhibits HIV-1 progeny formation

21 January 2018

1 reference

The CDK inhibitor p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages

21 January 2018

1 reference

Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers

21 January 2018

1 reference

CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21

21 January 2018

1 reference

The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity

21 January 2018

1 reference

Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication

21 January 2018

1 reference

Transportin-SR2 imports HIV into the nucleus

21 January 2018

1 reference

Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes.

21 January 2018

1 reference

The TRIM family protein KAP1 inhibits HIV-1 integration.

21 January 2018

1 reference

Control of HIV latency by epigenetic and non-epigenetic mechanisms

21 January 2018

1 reference

Laureate ESCI award for excellence in clinical science 1999. Cytokines and the human immunodeficiency virus: from bench to bedside. European Society for Clinical Investigation

21 January 2018

1 reference

JAK and STAT signaling molecules in immunoregulation and immune-mediated disease

21 January 2018

1 reference

Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression

21 January 2018

1 reference

The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells

21 January 2018

1 reference

Negative regulation of HIV-1 transcription by a heterodimeric NF-κB1/p50 and C-terminally truncated STAT5 complex

21 January 2018

1 reference

Origin and evolution of TRIM proteins: new insights from the complete TRIM repertoire of zebrafish and pufferfish

21 January 2018

1 reference

Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals

21 January 2018

1 reference

Restriction factors of retroviral replication: the example of Tripartite Motif (TRIM) protein 5 alpha and 22.

21 January 2018

1 reference

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

21 January 2018

1 reference

The control of viral infection by tripartite motif proteins and cyclophilin A.

21 January 2018

1 reference

Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression

21 January 2018

1 reference

Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages

21 January 2018

1 reference

TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements

21 January 2018

1 reference

The interferon response inhibits HIV particle production by induction of TRIM22

21 January 2018

1 reference

A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells

21 January 2018

1 reference

Regulating the regulators: control of protein ubiquitination and ubiquitin-like modifications by extracellular stimuli

21 January 2018

1 reference

Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain

21 January 2018

1 reference

TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus.

21 January 2018

1 reference

Epigenetic regulation of HIV latency

21 January 2018

1 reference

Gene silencing in HIV-1 latency by polycomb repressive group

21 January 2018

1 reference

Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2.

21 January 2018

1 reference

Paucity of HIV DNA methylation in latently infected, resting CD4+ T cells from infected individuals receiving antiretroviral therapy

21 January 2018

1 reference

Recruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cells

21 January 2018

1 reference

p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1.

21 January 2018

1 reference

LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing

21 January 2018

1 reference

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

21 January 2018

1 reference

Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation

21 January 2018

1 reference

Amino acid starvation induces reactivation of silenced transgenes and latent HIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4)

21 January 2018

1 reference

"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence

21 January 2018

1 reference

The role of cellular factors in promoting HIV budding

21 January 2018

1 reference

Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release

21 January 2018

1 reference

Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding

21 January 2018

1 reference

Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines

21 January 2018

1 reference

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

21 January 2018

1 reference

Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction

21 January 2018

1 reference

Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherin

21 January 2018

1 reference

Human immunodeficiency virus and papovavirus infections in acquired immunodeficiency syndrome: an ultrastructural study of three cases

21 January 2018

1 reference

Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells

21 January 2018

1 reference

Infectious HIV-1 assembles in late endosomes in primary macrophages

21 January 2018

1 reference

Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body

21 January 2018

1 reference

In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53.

21 January 2018

1 reference

Macrophage polarization and HIV-1 infection.

21 January 2018

1 reference

APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells.

21 January 2018

1 reference

Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages.

21 January 2018

1 reference

Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study

21 January 2018

1 reference

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

21 January 2018

1 reference

Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TAN.12047

1 reference

1 August 2017

1 reference